This inventor holds 1 USPTO granted patent. Top assignee: Archimica Gmbh. Active years: 2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2011
Title: James E. Aldred, Jr.: Inventor in Pharmaceutical Chemistry.
Introduction
James E. Aldred, Jr. is an inventor associated with Springfield, Missouri, and Archimica GmbH. His patent work concerns a process for preparing d-threo-methylphenidate hydrochloride through enantiomeric resolution.
Latest Patents
Aldred is credited with 1 patent: “Process of Enantiomeric Resolution of D,L-(±)-Threo-Methylphenidate.” The process resolves racemic threo-methylphenidate hydrochloride using less than a stoichiometric amount of tertiary amine base to form a methylphenidate–chiral acid salt. The salt is then basified to obtain methylphenidate free base, which is converted into d-threo-methylphenidate hydrochloride.
Career Highlights
Aldred’s listed patent reflects work on a chemical process for separating and preparing a specific methylphenidate isomer. He is associated with Archimica GmbH.
Collaborations
Thomas J. Marren and Yu Ji are identified as Aldred’s coworkers.
Conclusion
James E. Aldred, Jr.’s recorded invention focuses on enantiomeric resolution and the preparation of d-threo-methylphenidate hydrochloride.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile